Ranjan Dutta

Using molecular tools to understand the role of neurons and glial cells underlying the pathogenesis of progressive Multiple Sclerosis. Tweets are my opinion.

[Ranjan Dutta @Duttalab2017]

@SaligramaLab Congratulations 🎉

[Ranjan Dutta @Duttalab2017]

Congratulations Paul. @TesarLab
https://t.co/Pt9dfuMYtX

[Ranjan Dutta @Duttalab2017]

Great study by Crocker lab @GlialLab showing effects of senolytic treatment on OPCs and demyelination.

[Andrew Octavian Sasmita @AOSasmita]

Senolytic treatment induces oligodendrocyte dysfunction and demyelination in the corpus callosum

https://t.co/nlx1qiaXMF

[Ranjan Dutta @Duttalab2017]

Congratulations Josh @JoshuaBurda Sarah and the entire team.

[Josh Burda @JoshuaBurda]

Our new work identifies multiple lesion-remote astrocyte (LRA) subtypes across spared regions of the injured spinal cord.

LRAs exhibit anatomical region-restricted reactivity states with potential circuit-specific and immunomodulatory functions.

@Nature
https://t.co/iduxYx9OLe

[Ranjan Dutta @Duttalab2017]

@mikepberk @JustinLathia @CCLRI Congratulations Justin 🎉

[Ranjan Dutta @Duttalab2017]

@Aditya_S_Pandey @umichneuro @UMRogelCancer @umichmedicine @UMneurosciences Congratulations Maria 👏👏

[Ranjan Dutta @Duttalab2017]

Congratulations @Calabre04804429 for your election to the National
Academy of Medicine. Thank you for your contributions towards increasing our understanding of MS pathogenesis. #MSpathogenesis @UVMLarnerMed

[The Robert Larner, M.D. College of Medicine @UVMLarnerMed]

National Academy of Medicine announces election of Peter A. Calabresi, M.D.—professor and chair, Dept. of Neurological Sciences at #UVMLarnerMed—as a new member, due to his leadership in #MS pathogenesis/therapies: https://t.co/n4QWjNULMk @theNAMedicine @UVMResearch @uvmvermont

[ACTRIMS® @ACTRIMS]

Be a Part of ACTRIMS Forum 2026!

From February 5-7, we’re bringing together top researchers, clinicians, and MS experts in beautiful San Deigo, CA. Be part of the discussions shaping the future of MS research and care.

Register now to secure your spot! https://t.co/BUgZbLLmgu

[ACTRIMS® @ACTRIMS]

Regular abstract submission is open for #ACTRIMSForum 2026!
ACTRIMS encourages the submission of abstracts on any research or clinical topic related to MS and other neuroimmunological disorders.

Deadline: October 17, 2025

Submit here: https://t.co/moyqOWH0rs
#MSResearch

[Ranjan Dutta @Duttalab2017]

@OConnorVirusLab

[Ranjan Dutta @Duttalab2017]

@JustinLathia @NatalieCainSci @CellReports Great to attend the in-person seminar by @NatalieCainSci. Thanks to LRI Faculty development center and @JustinLathia and @longworth724. Special thanks to Christine O’Connor (not sure if she is on X) for asking the important questions that benefited all of us.

[Ranjan Dutta @Duttalab2017]

@JustinLathia @NatalieCainSci @CellReports Great to attend the in-person seminar by @NatalieCainSci. Thanks to LRI Faculty development center and @JustinLathia and @longworth724. Special thanks to Christine O’Connor (not sure if she is on X) for asking the important questions that benefited all of us.

[Ranjan Dutta @Duttalab2017]

@chopralab Congratulations Gaurav. 👏👏👏

[ACTRIMS® @ACTRIMS]

Learn from Tirisham Gyang on why she thinks the ACTRIMS Young Scientist Summit is so important! Applications close next week—Friday, March 7, 2025!

🗓️ May 5 – May 8, 2025
📍 Hotel Valley Ho, Scottsdale, AZ

Apply today before it's too late: https://t.co/AVuNt77e3l
#ACTRIMS

[ACTRIMS® @ACTRIMS]

Have you heard about the ACTRIMS Young Scientist Summit? Check out highlights from last year and see how the ACTRIMS Young Scientist Summit empowers the next generation of MS researchers.

learn more and apply today: https://t.co/9z0ePl3dpF
#ACTRIMS #YoungScientistSummit

[ACTRIMS® @ACTRIMS]

Applications for the Young Scientist Summit in Clinical Neuroimmunology 2025 are now open!

📅 When: Monday, May 5 – Thursday, May 8, 2025
📍 Where: Hotel Valley Ho, Scottsdale, AZ

Apply by: March 7, 2025

Learn more and apply here: https://t.co/nKBE0un7zh
#ACTRIMS #MSResearch

[Ranjan Dutta @Duttalab2017]

@SaligramaLab Congrats Naresha🥂. Great way to start the New Year.

[ACTRIMS® @ACTRIMS]

We mourn the loss of Prof Giancarlo Comi, a pioneering neurologist who advanced MS research and care.

As a founding leader of ECF and ACTRIMS partner since 2020, his visionary work shaped neurology and patient care.

Our condolences to his loved ones. His legacy inspires us all.

[ECTRIMS @ECTRIMS]

We mourn the loss of Prof. Giancarlo Comi, a pioneering neurologist in multiple sclerosis research. As a former ECTRIMS council member and European Charcot Foundation (@EuropeanCharcot) founder, his contributions have profoundly shaped the field and patient care globally.

[ACTRIMS® @ACTRIMS]

Abstract Submissions are OPEN for #ACTRIMSForum 2025!

We’re now accepting abstracts on any topic related to MS and neuroimmunology, including research studies, case descriptions, and protocol designs.

Deadline: October 25, 2024
For details, visit: https://t.co/uBWVSHbTqW

[MSJ @MSJ_Research]

#ECTRIMS2024 is beginning! We are here with our 4k followers 📣

Stay tuned for updates on #MSResearch @ECTRIMS